OTC ad spend in Australia will be 64% higher than it was in 2019, Zenith reports

Advertising expenditure by over-the-counter (OTC) healthcare brands in 13 key markets is predicted to expand by 7.6% in 2022 and 5.0% in 2023, according to Zenith’s new Business Intelligence – OTC Healthcare report, published today.

This growth, the report said, will be driven by tailored digital brand advertising, as well as performance advertising driving traffic to OTC ecommerce platforms.

Subscribe to keep reading

Join Mumbrella Pro to access the Mumbrella archive and read our premium analysis of everything under the media and marketing umbrella.

Subscribe

Get the latest media and marketing industry news (and views) direct to your inbox.

Sign up to the free Mumbrella newsletter now.

"*" indicates required fields

 

SUBSCRIBE

Sign up to our free daily update to get the latest in media and marketing.